Clinical recognition and management of patients exposed to biological warfare agents

被引:476
作者
Franz, DR
Jahrling, PB
Friedlander, AM
McClain, DJ
Hoover, DL
Bryne, WR
Pavlin, JA
Christopher, CW
Eitzen, EM
机构
[1] USA, MED RES INST INFECT DIS, FT DETRICK, MD 21702 USA
[2] USA, WALTER REED ARMY INST RES, MED RES & MAT COMMAND, WASHINGTON, DC 20310 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1997年 / 278卷 / 05期
关键词
D O I
10.1001/jama.278.5.399
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Concern regarding the use of biological agents-bacteria, viruses, or toxins-as tools of warfare or terrorism has led to measures to deter their use or, failing that, to deal with the consequences. Unlike chemical agents, which typically lead to violent disease syndromes within minutes at the site of exposure, diseases resulting from biological agents have incubation periods of days. Therefore, rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. We provide here a primer on 10 classic biological warfare agents to increase the likelihood of their being considered in a differential diagnosis. Although the resultant diseases are rarely seen in many countries today, accepted diagnostic and epidemiologic principles apply; if the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.
引用
收藏
页码:399 / 411
页数:13
相关论文
共 146 条
[1]   PATHOLOGY OF INHALATIONAL ANTHRAX IN 42 CASES FROM THE SVERDLOVSK OUTBREAK OF 1979 [J].
ABRAMOVA, FA ;
GRINBERG, LM ;
YAMPOLSKAYA, OV ;
WALKER, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2291-2294
[2]   VACCINE PROPHYLAXIS OF Q-FEVER - A FOLLOW-UP-STUDY OF THE EFFICACY OF Q-VAX (CSL) 1985-1990 [J].
ACKLAND, JR ;
WORSWICK, DA ;
MARMION, BP .
MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (11) :704-708
[3]  
[Anonymous], 1980, REPORT INVESTIGATION
[4]  
[Anonymous], 1989, BOTULINUM NEUROTOXIN
[5]   VIROLOGICAL EVIDENCE FOR THE SUCCESS OF THE SMALLPOX ERADICATION PROGRAM [J].
ARITA, I .
NATURE, 1979, 279 (5711) :293-298
[6]  
ARIZA J, 1985, REV INFECT DIS, V7, P656
[7]   PROPHYLAXIS OF SMALLPOX WITH METHISAZONE [J].
BAUER, DJ ;
STVINCEN.L ;
KEMPE, CH ;
YOUNG, PA ;
DOWNIE, AW .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 90 (02) :130-&
[8]  
BAUER DJ, 1963, LANCET, V2, P494
[9]  
Bavari S, 1996, VACCINES, P135
[10]   RECURRENT REACTION AT SITE OF Q FEVER VACCINATION IN SENSITIZED PERSON [J].
BELL, JF ;
LACKMAN, DB ;
MEIS, A ;
HADLOW, WJ .
MILITARY MEDICINE, 1964, 129 (07) :591-&